Company intelligence / Profile preview

iZafe Group

Stockholm, Sweden

Ownership: Private
Employees: ~7
Development stage: Other

Overview

iZafe Group commercially markets Dosell, an automated medication dispensing robot, and Pilloxa, a SaaS-based adherence and data platform with a smart pillbox, to reduce medication errors at home, improve adherence, and support clinical trials and healthcare workflows.[1][3][6]

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapySoftware as a service
Industry: Therapeutic Medical Devices

Partnerships

Vakt og Alarm AS – strategic distribution, installation and support partner for Dosell in Norway[2]UMO/UMOcx platform integration for digital care and alarm services in the Nordics[2]

Beyond the preview

Go deeper on iZafe Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iZafe Group.

Explore the full profile